Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Bao V. Duong, Puchanee Larpruenrudee, Tianxin Fang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4586-4586
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 190
Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis
Min Du, Yirui Ma, Jie Deng, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 16010-16010
Open Access | Times Cited: 86
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant
Robert Flisiak, Dorota Zarębska‐Michaluk, Krystyna Dobrowolska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5572-5572
Open Access | Times Cited: 17
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3–17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial
Lidong Gao, Yan Li, Peng He, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 4, pp. 269-279
Open Access | Times Cited: 16
Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants
Tanmay Ghildiyal, Nishant Rai, Janhvi Mishra Rawat, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 6
Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics
Xia Jiang, Dabing Li, Mazaher Maghsoudloo, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104026-104026
Closed Access | Times Cited: 6
Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan
Takahito Mizuno, Yu Kondo, Mikiyasu Sakai, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 716-724
Closed Access | Times Cited: 5
Assessing the impact of Australia’s mass vaccination campaigns over the Delta and Omicron outbreaks
Lixin Lin, Haydar Demirhan, Simon P. Johnstone-Robertson, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299844-e0299844
Open Access | Times Cited: 5
Viral nucleic acid load in the milk of lactating mothers with COVID-19 and the prognosis of infants
Mengkun Wang, Yifei Li, Jie Lei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies
Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1263-1263
Open Access
Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico
Lilliana Serrano-Arroyo, Ariana González-Meléndez, Rafael Ríos-Rivera, et al.
Lupus (2025)
Closed Access
Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
Yajuan Zhu, Shuang Liu, Dingmei Zhang
Vaccines (2022) Vol. 10, Iss. 9, pp. 1396-1396
Open Access | Times Cited: 25
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study
Jingxing Li, Pei‐Lun Liao, James Cheng‐Chung Wei, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination
Sarita Bugalia, Jai Prakash Tripathi, Hao Wang
Journal of Mathematical Biology (2024) Vol. 88, Iss. 4
Closed Access | Times Cited: 4
Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients
Paweł Poznański, Hanna Augustyniak‐Bartosik, Anna Magiera-Żak, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2224-2224
Open Access | Times Cited: 21
A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study
Nhi Nguyen, Tsong‐Yih Ou, Lê Đức Huy, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
Aprotinin—Drug against Respiratory Diseases
Alexandre V. Ivachtchenko, Andrey A. Ivashchenko, Dmitrii O. Shkil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11173-11173
Open Access | Times Cited: 10
Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021–January 2022
G. V. Gerashchenko, N. V. Hryshchenko, Nataliia Melnichuk, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25618-e25618
Open Access | Times Cited: 3
Narrative Review Explaining the Role of HLA-A, -B, and -C Molecules in COVID-19 Disease in and around Africa
Lisa Naidoo, Thilona Arumugam, Veron Ramsuran
Infectious Disease Reports (2024) Vol. 16, Iss. 2, pp. 380-406
Open Access | Times Cited: 3
Spatiotemporal transmission of SARS-CoV-2 lineages during 2020–2021 in Pernambuco—Brazil
Laís Ceschini Machado, Filipe Zimmer Dezordi, Gustavo Barbosa de Lima, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Cleavage of the selective autophagy receptor SQSTM1/p62 by the SARS-CoV-2 main protease NSP5 prevents the autophagic degradation of viral membrane proteins
Yabin Zhang, Shiyan Liu, Qingjia Xu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
Mohammad Mamun Alam, Sumaiya Binte Hannan, Tanvir Ahmed Saikat, et al.
Evolutionary Bioinformatics (2023) Vol. 19
Open Access | Times Cited: 9
Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry
Raghubir S Khedar, Rajeev Gupta, Krishnakumar Sharma, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e067430-e067430
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top